Sutro Biopharma, Inc.STRONASDAQ

Revenue (LTM)

$62M

-59.6% YoY

Net Income (LTM)

$-227M

-113.0% YoY

Free Cash Flow

$-195M

Revenue CAGR (5Y)

+7.7%

Marginsimproving

FCF($0.2B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	43	62↑44.8%	68↑9.5%	154↑126.8%	62↓59.6%
Gross Profit	-34	52↑252.2%	59↑14.2%	147↑147.0%	55↓62.7%
Operating Income	-71	-99↓38.7%	-129↓30.9%	-89↑30.8%	-238↓167.1%
Net Income	-32	-106↓228.5%	-119↓12.9%	-107↑10.4%	-227↓113.0%
EBITDA	-24	-98↓310.7%	-105↓7.7%	-68↑35.4%	-180↓165.7%
EPS Diluted	-9.90	-22.90↓131.3%	-23.50↓2.6%	-17.80↑24.3%	-29.60↓66.3%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	206	30↓85.2%	47↑55.4%	69↑46.6%	190↑174.7%
Total Current Assets	378	219↓42.2%	353↑61.6%	422↑19.4%	343↓18.6%
Total Assets	394	341↓13.4%	407↑19.2%	471↑15.7%	387↓17.7%
Total Current Liabilities	30	42↑41.0%	67↑59.4%	94↑40.9%	132↑40.7%
Total Liabilities	62	89↑43.2%	190↑113.7%	321↑69.1%	343↑6.7%
Total Equity	332	253↓23.9%	217↓14.1%	150↓31.1%	45↓70.2%
Total Debt	25	57↑133.8%	55↓4.1%	34↓38.9%	23↓31.2%
Net Debt	-182	27↑114.8%	8↓71.2%	-36↓559.1%	-167↓369.1%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-68	-82↓20.5%	4↑104.3%	-112↓3245.0%	-192↓71.6%
Capital Expenditure	-7	-15↓114.9%	-8↑48.7%	-4↑45.1%	-3↑28.2%
Free Cash Flow	-75	-97↓29.5%	-4↑95.6%	-116↓2590.4%	-195↓67.9%
Stock-Based Comp	12	23↑95.0%	26↑13.2%	25↓5.3%	25↓0.9%
Net Change in Cash	202	-176↓187.0%	17↑109.6%	22↑30.7%	121↑449.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance